Article
Targeting of a STING Agonist to Perivascular Macrophages in Prostate Tumors Delays…
medRxiv · 2024 · Al-janabi, H.; Moyes, K.; Allen, R. J.; Fisher, M.; Crespo, M.; Gurel, B.; Rescigno, P.; De Bono, J.; Nunns, H.; Bailey, C.; Juncker-Jensen, A.; Muthana, M.; Phillips, W. A.; Pearson, H.; Taplin, M.-E.; Brown, J. E.; Lewis, C. E.
Key facts
| Title | Targeting of a STING Agonist to Perivascular Macrophages in Prostate Tumors Delays Resistance to Androgen Deprivation Therapy |
|---|---|
| First author | Al-janabi, H.; Moyes, K.; Allen, R. J.; Fisher, M.; Crespo, M.; Gurel, B.; Rescigno, P.; De Bono, J.; Nunns, H.; Bailey, C.; Juncker-Jensen, A.; Muthana, M.; Phillips, W. A.; Pearson, H.; Taplin, M.-E.; Brown, J. E.; Lewis, C. E. |
| Journal | medRxiv |
| Published | Apr 12, 2024 |
| DOI | 10.1101/2024.04.11.589003 |
| Product codes mentioned | KIT |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1